Efficacy Study of add-on Therapy With N-Acetylcysteine in Resistant Obsessive-compulsive Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Obsessive-Compulsive Disorder
Interventions
DRUG

N-Acetylcysteine (NAC)

Week 1: 1200 mg (one 600 mg capsule twice a day) Week 2: 2400 mg (two 600 mg capsules twice a day) Weeks 3-16: 3000 mg (two 600 mg capsules in the morning and 3 in the evening)

DRUG

Placebo

Week 1: one capsule twice a day Week 2: two capsules twice a day Weeks 3-16: two capsules in the morning and 3 in the evening

Trial Locations (1)

01060-970

Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo

All Listed Sponsors
lead

University of Sao Paulo

OTHER

collaborator

Fundação de Amparo à Pesquisa do Estado de São Paulo

OTHER_GOV

NCT01555970 - Efficacy Study of add-on Therapy With N-Acetylcysteine in Resistant Obsessive-compulsive Disorder | Biotech Hunter | Biotech Hunter